REGENEREX PHARMA, INC. Proceeds from Warrant Exercises
REGENEREX PHARMA, INC. reported Proceeds from Warrant Exercises of $50.00 thousand for the 9-month period ending 2025-12-31, per its 10-KT filed 2026-08-31.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromWarrantExercises · last filed 2026-08-31
- REGENEREX PHARMA, INC. proceeds from warrant exercises for fiscal 2025 was $0.00.
| Period end | Proceeds from Warrant Exercises 9 month | Proceeds from Warrant Exercises 12 month |
|---|---|---|
| 2025-12-31 | $50.00K 10-KT · filed 2026-08-31 | |
| 2025-03-31 | $0.00 10-KT · filed 2026-08-31 |